TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 299 filers reported holding TANDEM DIABETES CARE INC in Q4 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $564,321 | -5.4% | 27,170 | +11.8% | 0.47% | +4.5% |
Q2 2023 | $596,322 | -37.2% | 24,300 | +4.0% | 0.45% | -39.5% |
Q1 2023 | $949,259 | -9.7% | 23,375 | 0.0% | 0.74% | -6.6% |
Q4 2022 | $1,050,706 | -6.0% | 23,375 | 0.0% | 0.79% | -17.0% |
Q3 2022 | $1,118,000 | -19.2% | 23,375 | 0.0% | 0.95% | -14.3% |
Q2 2022 | $1,384,000 | -49.1% | 23,375 | 0.0% | 1.11% | -38.8% |
Q1 2022 | $2,718,000 | -22.7% | 23,375 | 0.0% | 1.82% | -18.5% |
Q4 2021 | $3,518,000 | +24.7% | 23,375 | -1.0% | 2.23% | +7.4% |
Q3 2021 | $2,822,000 | +22.7% | 23,618 | +0.1% | 2.08% | +22.9% |
Q2 2021 | $2,299,000 | +10.5% | 23,603 | +0.1% | 1.69% | +1.9% |
Q1 2021 | $2,080,000 | -10.7% | 23,569 | -3.2% | 1.66% | -17.1% |
Q4 2020 | $2,328,000 | -15.7% | 24,336 | +0.0% | 2.00% | -19.6% |
Q3 2020 | $2,761,000 | +18.9% | 24,327 | +3.6% | 2.49% | -2.5% |
Q2 2020 | $2,322,000 | +54.4% | 23,476 | +0.4% | 2.55% | +40.6% |
Q1 2020 | $1,504,000 | +8.0% | 23,375 | 0.0% | 1.82% | +22.1% |
Q4 2019 | $1,393,000 | – | 23,375 | – | 1.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |